Literature DB >> 11796561

The "no-reflow" phenomenon: basic science and clinical correlates.

Thorsten Reffelmann1, Robert A Kloner.   

Abstract

Mesh：

Year:  2002        PMID： 11796561      PMCID： PMC1767011          DOI： 10.1136/heart.87.2.162

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

1.  "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.

Authors:  K Przyklenk; R A Kloner
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

2.  Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.

Authors:  Y Taniyama; H Ito; K Iwakura; T Masuyama; M Hori; S Takiuchi; N Nishikawa; Y Higashino; K Fujii; T Minamino
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

3.  Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits.

Authors:  P Golino; M Ragni; P Cirillo; A Scognamiglio; A Ravera; C Buono; A Guarino; O Piro; C Lambiase; F Botticella; M Ezban; M Condorelli; M Chiariello
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

4.  Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow.

Authors:  G Ambrosio; H F Weisman; J A Mannisi; L C Becker
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

5.  Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon.

Authors:  K Iwakura; H Ito; N Nishikawa; K Hiraoka; K Sugimoto; Y Higashino; T Masuyama; M Hori; K Fujii; T Minamino
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

6.  Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty.

Authors:  G M Santoro; R Valenti; P Buonamici; L Bolognese; G Cerisano; G Moschi; M Trapani; D Antoniucci; P F Fazzini
Journal:  Am J Cardiol       Date:  1998-10-15       Impact factor: 2.778

7.  Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

Authors:  R N Piana; G Y Paik; M Moscucci; D J Cohen; C M Gibson; A D Kugelmass; J P Carrozza; R E Kuntz; D S Baim
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

8.  Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization.

Authors:  T Sakuma; Y Hayashi; K Sumii; M Imazu; M Yamakido
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

9.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?

Authors:  R A Kloner; R E Rude; N Carlson; P R Maroko; L W DeBoer; E Braunwald
Journal:  Circulation       Date:  1980-11       Impact factor: 29.690
View more
  69 in total

1.  Pathology of coronary microembolisation and no reflow.

Authors:  E Falk; L Thuesen
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.

Authors:  Bilian Zhao; Jian Li; Xinping Luo; Qing Zhou; Hua Chen; Haiming Shi
Journal:  Tex Heart Inst J       Date:  2011

3.  Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging.

Authors:  Suzanne de Waha; Steffen Desch; Ingo Eitel; Georg Fuernau; Philipp Lurz; Anja Leuschner; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2012-06       Impact factor: 5.460

4.  Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model.

Authors:  Stavros Stavrakis; John Terrovitis; Elias Tsolakis; Stavros Drakos; Argirios Dalianis; Michael Bonios; Dimitrios Koudoumas; Konstantinos Malliaras; John Nanas
Journal:  J Cardiovasc Transl Res       Date:  2010-12-09       Impact factor: 4.132

5.  Relationship between residual viable myocardium and LV remodeling post-MI: Only part of the story.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

6.  Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.

Authors:  Li Dong-bao; Hua Qi; Liu Zhi; Wang Shan; Jin Wei-ying
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

Review 7.  The pathology of myocardial infarction in the pre- and post-interventional era.

Authors:  M Pasotti; F Prati; E Arbustini
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 8.  The pathophysiology of myocardial reperfusion: a pathologist's perspective.

Authors:  C Basso; G Thiene
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

Review 9.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

10.  Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.

Authors:  J Grönros; A Kiss; M Palmér; C Jung; D Berkowitz; J Pernow
Journal:  Acta Physiol (Oxf)       Date:  2013-04-15       Impact factor: 6.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.